| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | MANGOCEUTICALS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.01. | MANGOCEUTICALS, INC. - S-1/A, General form for registration of securities | 1 | SEC Filings | ||
| 13.01. | MANGOCEUTICALS, INC. - S-1, General form for registration of securities | 1 | SEC Filings | ||
| 19.12.25 | Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements | 2 | GlobeNewswire (USA) | ||
| MANGOCEUTICALS Aktie jetzt für 0€ handeln | |||||
| 19.12.25 | Mangoceuticals announces $100 million Solana-focused strategy | 2 | Investing.com | ||
| 19.12.25 | Mangoceuticals setzt auf Solana: Neue Treasury-Strategie über 100 Millionen US-Dollar | 1 | Investing.com Deutsch | ||
| 19.12.25 | Mangoceuticals, Inc. Announces Partnership with The Cube Group to Launch Up To $100 Million Solana-Focused Digital Asset Treasury (DAT) Strategy | 7 | GlobeNewswire (USA) | ||
| 19.12.25 | MANGOCEUTICALS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 18.12.25 | Mangoceuticals prices $2.5M registered direct offering with warrants | 1 | Seeking Alpha | ||
| 18.12.25 | Mangoceuticals secures $2.5 million through registered direct offering | 4 | Investing.com | ||
| 18.12.25 | Mangoceuticals, Inc. Announces $2.5 Million Registered Direct and Private Placements Priced at the Market Under Nasdaq Rules | 1 | GlobeNewswire (USA) | ||
| 10.12.25 | MANGOCEUTICALS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 14.11.25 | MANGOCEUTICALS, INC. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 14.11.25 | Eli Lilly and Novo Nordisk disown Mangoceuticals' GLP-1RA partnership claim | 39 | Pharmaceutical Technology | ||
| 14.11.25 | Mangoceuticals plunges after denying Lilly, Novo partnerships | 22 | Seeking Alpha | ||
| 14.11.25 | Mangoceuticals, Inc.: Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs | 2.203 | GlobeNewswire (Europe) | Dallas, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceuticals" or the "Company") is issuing the following clarification regarding its press release issued earlier... ► Artikel lesen | |
| 13.11.25 | Lilly, Novo shoot down claims of DTC obesity drug partnership with Mangoceuticals | 39 | FiercePharma | ||
| 13.11.25 | Mangoceuticals: Aktie stürzt nach Dementi von Novo Nordisk und Eli Lilly ab | 53 | Investing.com Deutsch | ||
| 13.11.25 | Lilly, Novo in pact with Mangoceuticals for direct sales of weight loss drugs | 50 | Seeking Alpha | ||
| 13.11.25 | Mangoceuticals launches direct GLP-1 medication access programs | 21 | Investing.com |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SPINEWAY | 0,171 | +6,06 % | SPINEWAY: 2025 revenue of €12.4 million, with an acceleration of sales in Q4 2025 (+34%) | Ecully, January 13, 2026 - 6:30 p.m. SPINEWAY 2025 revenue of €12.4 million, with an acceleration of sales in Q4 2025 (+34%) In thousands of euros20252024Change as a %H1 revenue5,5736,535-15%H2... ► Artikel lesen | |
| ASENSUS SURGICAL | - | - | GlobalLogic, Asensus ink surgical robotics engineering collab | ||
| NUWELLIS, INC | 2,610 | +5,67 % | Nuwellis, Inc.: Nuwellis Appoints Carisa Schultz as Chief Financial Officer | MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) a medical technology company focused on advancing precision cardiorenal care, today announced the appointment of Carisa... ► Artikel lesen | |
| LOGICMARK | - | - | LogicMark, Inc. Announces Third Quarter 2025 Results | LOUISVILLE, Ky., Nov. 12, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc.?(OTC: LGMKD) (the Company), a provider of personal safety and emergency response systems (PERS), health communications devices, and... ► Artikel lesen | |
| ENVUE MEDICAL | 2,960 | +3,14 % | Morning Market Movers: Silicon Laboratories, Concorde International Group, ENvue Medical, Enphase Energy See Big Swings | SUNNYVALE (dpa-AFX) - At 7:55 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 41,400 | -2,82 % | DAX-Konzern Siemens Healthineers legt Zahlen vor | Siemens Healthineers startet solide ins neue Geschäftsjahr und bestätigt den Jahresausblick, wird aber vom schwachen Diagnostikgeschäft in China gebremst. Der DAX-Konzern Siemens Healthineers ist mit... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,640 | +0,40 % | Fresenius Medical Care: Ein Neuanfang nach turbulenten Zeiten? | ||
| FRESENIUS | 49,760 | +1,06 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Fresenius mit einem Kursziel von 55 Euro auf "Buy" belassen. Die Bad Homburger seien in Verjüngungskur, und der Markt preise... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 28,740 | +4,89 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 39,680 | +3,44 % | BrightSpring Health Services, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026 | ||
| CARL ZEISS MEDITEC | 27,520 | +0,66 % | ANALYSE-FLASH: Barclays senkt Carl Zeiss Meditec auf 'Equal Weight' | LONDON (dpa-AFX Broker) - Die britische Investmentbank Barclays hat das Kursziel für Carl Zeiss Meditec von 49 auf 32 Euro gesenkt und die Aktien von "Overweight" auf "Equal Weight" abgestuft. Nur... ► Artikel lesen | |
| HEARTFLOW | 27,690 | +6,54 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| GENEDX | 84,35 | +0,32 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 21,990 | +2,23 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| GERRESHEIMER | 25,660 | +1,99 % | JEFFERIES stuft GERRESHEIMER AG auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Gerresheimer mit einem Kursziel von 34,10 Euro auf "Buy" belassen. Analyst James Vane-Tempest zählt den Spezialverpackungshersteller... ► Artikel lesen |